A New Experimental Vaccine Targets Rogue Genes Linked To 90 Percent Of Pancreatic Cancers
Favicon 
www.iflscience.com

A New Experimental Vaccine Targets Rogue Genes Linked To 90 Percent Of Pancreatic Cancers

It's still early days, but the investigational vaccine offers hope for patients with this aggressive form of cancer.